In animal study, NLRP3 (an inflammasome sensor)-deficient APP/PS1 AD mice showed improved Aβ clearance by microglia, lower Aβ-induced IL-1β formation in the brain, and decreased the Aβ-induced suppression of synaptic plasticity [18]. This evidence concerns the gene IL1B and Alzheimer disease.